Lymphoblastic Lymphoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: LYM040 MIFTS: 57	Lymphoblastic Lymphoma Categories: Blood diseases, Cancer diseases, Immune diseases, Rare diseases
Genes Tissues Related diseases Publications Pathways Drugs Expand all tables

Sources

Aliases & Classifications for Lymphoblastic Lymphoma

MalaCards integrated aliases for Lymphoblastic Lymphoma:

Name: Lymphoblastic Lymphoma ³⁸ ¹² ⁷⁶ ⁵³ ¹⁵

Precursor Cell Lymphoblastic Leukemia Lymphoma ⁷³

Precursor Cell Lymphoblastic Lymphoma ⁷³

Lymphoma, Lymphoblastic ⁵³

Lymphoma Lymphoblastic ⁵⁵

Classifications:

MalaCards categories:
Global: Rare diseases Cancer diseases
Anatomical: Blood diseases Immune diseases

See all MalaCards categories (disease lists)

ICD10: ³³

Neoplasms

Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue

Non-follicular lymphoma

Lymphoblastic (diffuse) lymphoma

External Ids:

Disease Ontology ¹² DOID:0080147

ICD10 ³³ C83.5

UMLS ⁷³ C0079748 C1961102

Sources

Summaries for Lymphoblastic Lymphoma

Disease Ontology : ¹² A lymphoma that has material basis in immature malignant lymphocytes (lymphoblasts) committed to the B-cell or T-cell lineage and located in primarily lymph nodes or located in extranodal sites.

MalaCards based summary : Lymphoblastic Lymphoma, also known as precursor cell lymphoblastic leukemia lymphoma, is related to acute t cell leukemia and leukemia, acute lymphoblastic. An important gene associated with Lymphoblastic Lymphoma is ZMYM2 (Zinc Finger MYM-Type Containing 2), and among its related pathways/superpathways are NF-kappaB Signaling and Transcriptional misregulation in cancer. The drugs Arranon and Prednisolone phosphate have been mentioned in the context of this disorder. Affiliated tissues include t cells, bone and bone marrow, and related phenotypes are Reduced mammosphere formation and hematopoietic system

Wikipedia : ⁷⁶ Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the... more...

Sources

Related Diseases for Lymphoblastic Lymphoma

Diseases related to Lymphoblastic Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 152)

#	Related Disease	Score	Top Affiliating Genes
1	acute t cell leukemia	32.1	NOTCH1 TAL1 TRB
2	leukemia, acute lymphoblastic	30.9	DNTT KMT2A MME
3	lymphocytic leukemia	30.3	CD5 DNTT KMT2A MME NOTCH1 TAL1
4	leukemia, acute lymphoblastic 3	30.1	CDKN2B DNTT KMT2A MME MPO
5	acute lymphocytic leukemia	30.0	CDKN2B MME NOTCH1 TAL1
6	acute leukemia	29.8	DNTT KMT2A MPO TAL1
7	8p11 myeloproliferative syndrome	29.8	FGFR1 ZMYM2
8	myeloid sarcoma	29.7	DNTT KMT2A MPO PTPRC
9	lymphosarcoma	29.7	BCL6 CD5 PTPRC
10	thymoma	29.7	CD5 DNTT PTPRC TRB
11	ewing's family of tumors	29.7	CDKN2B FLI1
12	peripheral t-cell lymphoma	29.6	BCL6 CD5 MME
13	diffuse large b-cell lymphoma	29.6	BCL6 CD5 MME
14	burkitt lymphoma	29.6	BCL6 DNTT MME
15	b-cell lymphomas	29.6	BCL6 CD5 MME
16	acute biphenotypic leukemia	29.6	DNTT KMT2A MPO
17	dendritic cell tumor	29.5	DNTT MPO PTPRC
18	pediatric lymphoma	29.5	DNTT MME
19	lymphoma, hodgkin, classic	29.5	BCL6 CD5 MME PTPRC
20	leukemia, chronic myeloid	29.5	CDKN2B DNTT FGFR1 KMT2A MPO
21	mantle cell lymphoma	29.2	BCL6 CD5 MME PTPRC
22	leukemia, chronic lymphocytic	29.2	BCL6 CD5 DNTT NOTCH1 PTPRC
23	leukemia, acute myeloid	29.2	CDKN2B DNTT KMT2A MME MPO PTPRC
24	lymphoma, non-hodgkin, familial	29.0	BCL6 CD5 CDKN2B DNTT MME NOTCH1
25	precursor t-cell acute lymphoblastic leukemia	28.8	CDKN2B DNTT KMT2A MPO NOTCH1 TAL1
26	t-cell childhood lymphoblastic lymphoma	12.5
27	precursor t-lymphoblastic lymphoma/leukemia	12.4
28	precursor b lymphoblastic lymphoma/leukemia	12.2
29	precursor lymphoblastic lymphoma/leukemia	12.2
30	childhood precursor t-lymphoblastic lymphoma/leukemia	12.1
31	precursor t-lymphoblastic lymphoma/leukemia refractory	12.1
32	chromosome 8p11 myeloproliferative syndrome	11.2
33	lymphoma	11.1
34	leukemia	10.6
35	myasthenic syndrome, congenital, 6, presynaptic	10.2	FGFR1 ZMYM2
36	photokeratitis	10.2	DNTT PTPRC
37	chromosomal triplication	10.2	BCL6 KMT2A
38	immunodeficiency 18	10.2	PTPRC TAL1
39	hodgkin's lymphoma, lymphocytic-histiocytic predominance	10.2	BCL6 PTPRC
40	sarcoma	10.1
41	ovarian lymphoma	10.1	MME PTPRC
42	hematopoietic stem cell transplantation	10.1
43	t-cell/histiocyte rich large b cell lymphoma	10.1	BCL6 MME
44	breast lymphoma	10.1	BCL6 CD5
45	extraskeletal ewing sarcoma	10.1	FLI1 PTPRC
46	myeloproliferative neoplasm	10.1
47	composite lymphoma	10.1	BCL6 CD5
48	erythroleukemia, familial	10.1	FLI1 TAL1
49	tracheal lymphoma	10.1	CD5 MME
50	central nervous system hematologic cancer	10.1	BCL6 MME

Graphical network of the top 20 diseases related to Lymphoblastic Lymphoma:

Sources

Symptoms & Phenotypes for Lymphoblastic Lymphoma

GenomeRNAi Phenotypes related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

²⁶

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Reduced mammosphere formation	GR00396-S	9.1	BCL6 CD5 KMT2A NOTCH1 PTPRC ZMYM2

MGI Mouse Phenotypes related to Lymphoblastic Lymphoma:

⁴⁶ (show all 11)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	hematopoietic system	MP:0005397	10.22	BCL6 CD5 CDKN2B DNTT FGFR1 FLI1
2	immune system	MP:0005387	10.21	BCL6 CD5 CDKN2B DNTT FGFR1 FLI1
3	homeostasis/metabolism	MP:0005376	10.16	BCL6 CDKN2B DNTT FGFR1 KMT2A MME
4	cardiovascular system	MP:0005385	10.1	BCL6 DNTT FGFR1 FLI1 KMT2A MPO
5	mortality/aging	MP:0010768	10.02	BCL6 CDKN2B FGFR1 FLI1 KMT2A MPO
6	integument	MP:0010771	9.95	CD5 CDKN2B FGFR1 KMT2A MME NOTCH1
7	liver/biliary system	MP:0005370	9.85	BCL6 FLI1 KMT2A MME NOTCH1 PTPRC
8	muscle	MP:0005369	9.73	BCL6 FGFR1 FLI1 KMT2A MPO NOTCH1
9	no phenotypic analysis	MP:0003012	9.63	BCL6 CD5 CDKN2B FGFR1 KMT2A PTPRC
10	normal	MP:0002873	9.5	BCL6 CD5 DNTT FGFR1 KMT2A NOTCH1
11	renal/urinary system	MP:0005367	9.1	CDKN2B FGFR1 KMT2A NOTCH1 PTPRC TAL1

Sources

Drugs & Therapeutics for Lymphoblastic Lymphoma

FDA approved drugs:

#	Drug Name	Active Ingredient(s) ¹⁸	Company	Approval Date
1	Arranon ¹⁸ ⁴⁹	NELARABINE	GlaxoSmithKline	October 2005
FDA Label: Arranon Disease/s that Drug Treats:Lymphoblastic Leukemia Indications and Usage: ¹⁸ ARRANON is a nucleoside metabolic inhibitor indicated for the treatment ofpatients with T-cell acute lymphoblastic leukemia and T-cell lymphoblasticlymphoma whose disease has not responded to or has relapsed followingtreatment with at least two chemotherapy regimens. This use is based on theinduction of complete responses. Randomized trials demonstrating increasedsurvival or other clinical benefit have not been conducted. (1) DrugBank Targets: ¹⁶ DNA Mechanism of Action: ¹⁸ Target: DNA synthesis Action: disruptor --> apoptosis FDA: Nelarabine is a pro-drug of the deoxyguanosine analogue 9-Î²-D-arabinofuranosylguanine266 (ara-G), a nucleoside metabolic inhibitor. Nelarabine is demethylated by adenosine deaminase267 (ADA) to ara-G, mono-phosphorylated by deoxyguanosine kinase and deoxycytidine kinase, and268 subsequently converted to the active 5â-triphosphate, ara-GTP. Accumulation of ara-GTP in269 leukemic blasts allows for incorporation into deoxyribonucleic acid (DNA), leading to inhibition270 of DNA synthesis and cell death. Other mechanisms may contribute to the cytotoxic and271 systemic toxicity of nelarabine.

Drugs for Lymphoblastic Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 493)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Prednisolone phosphate

Approved, Vet_approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

302-25-0

Prednisolone

Approved, Vet_approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

50-24-8

5755

Vincristine

Approved, Investigational

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

57-22-7, 2068-78-2

5978

Methotrexate

Approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

59-05-2, 1959-05-2

126941

Methylprednisolone

Approved, Vet_approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

83-43-2

6741

Methylprednisolone hemisuccinate

Approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

2921-57-5

Vindesine

Approved, Investigational

Phase 4,Phase 3,Phase 2

59917-39-4, 53643-48-4

40839

Cyclophosphamide

Approved, Investigational

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

6055-19-2, 50-18-0

2907

Thioguanine

Approved

Phase 4,Phase 3,Phase 2,Phase 1

154-42-7

2723601

Etoposide

Approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

33419-42-0

36462

Cytarabine

Approved, Investigational

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

147-94-4

6253

Doxorubicin

Approved, Investigational

Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable

23214-92-8

31703

Cladribine

Approved, Investigational

Phase 4,Phase 2,Phase 1

4291-63-8

20279

Daunorubicin

Approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

20830-81-3

30323

Dexamethasone acetate

Approved, Investigational, Vet_approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

1177-87-3

Dexamethasone

Approved, Investigational, Vet_approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

50-02-2

5743

leucovorin

Approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

58-05-9

6006 143

rituximab

Approved

Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable

174722-31-7

10201696

Ifosfamide

Approved

Phase 4,Phase 2,Phase 3,Phase 1

3778-73-2

3690

Lenograstim

Approved, Investigational

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

135968-09-1

Busulfan

Approved, Investigational

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

55-98-1

2478

Thiotepa

Approved, Investigational

Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

52-24-4

5453

Azacitidine

Approved, Investigational

Phase 4,Phase 2,Phase 1

320-67-2

9444

Morphine

Approved, Investigational

Phase 4,Phase 3,Not Applicable

57-27-2

5288826

Decitabine

Approved, Investigational

Phase 4,Phase 2,Phase 1

2353-33-5

451668

Epirubicin

Approved

Phase 4,Phase 2

56420-45-2

41867

Folic Acid

Approved, Nutraceutical, Vet_approved

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

59-30-3

6037

Prednisolone hemisuccinate

Experimental

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

2920-86-7

Doxil

Approved June 1999

Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable

31703

6-Mercaptopurine

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Prednisolone acetate

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Peripheral Nervous System Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Anti-Bacterial Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Anti-Inflammatory Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Antineoplastic Agents, Alkylating

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Antiviral Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

asparaginase

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Antimetabolites

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Etoposide phosphate

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Hormones

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Vitamin B Complex

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Anti-Infective Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Autonomic Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

BB 1101

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Immunosuppressive Agents

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Antimetabolites, Antineoplastic

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Antineoplastic Agents, Hormonal

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Hormone Antagonists

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Immunologic Factors

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Nucleic Acid Synthesis Inhibitors

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 655)

#	Name	Status	NCT ID	Phase	Drugs
1	German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults	Completed	NCT00199017	Phase 4	Dexamethasone/Prednisolone;Cyclophosphamide;Vincristine;Daunorubicin;Asparaginase;G-CSF;Mercaptopurine;Cytarabine;Methotrexate;VP16;Vindesine;Adriamycin;Thioguanine;HDARAC;Cladribine
2	Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults	Completed	NCT00199082	Phase 4	Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
3	Bone Marrow Transplantation in Treating Patients With Hematologic Cancer	Completed	NCT00003398	Phase 4	cyclophosphamide;thiotepa
4	A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma	Recruiting	NCT03558412	Phase 4	Decitabine
5	ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors	Recruiting	NCT02938741	Phase 4	Anti－human Thymoglobulin;Placebo
6	Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma	Unknown status	NCT00004228	Phase 3	asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;thioguanine;vincristine sulfate
7	Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma	Unknown status	NCT00003650	Phase 3	asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;vincristine sulfate
8	Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain	Unknown status	NCT01316744	Phase 3	ketamine hydrochloride
9	Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia	Unknown status	NCT00445497	Phase 3	amoxicillin-clavulanate potassium;ciprofloxacin
10	Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma	Unknown status	NCT00003423	Phase 3	asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
11	Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma	Unknown status	NCT00003728	Phase 3	asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;doxorubicin hydrochloride;etoposide;leucovorin calcium;mercaptopurine;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisolone;therapeutic hydrocortisone;thioguanine;vincristine sulfate;vindesine
12	Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia	Unknown status	NCT00020865	Phase 3	cefepime hydrochloride;levofloxacin
13	Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma	Unknown status	NCT00003338	Phase 2, Phase 3
14	Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma	Unknown status	NCT00003337	Phase 3
15	Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome	Unknown status	NCT00002989	Phase 3	busulfan;cyclophosphamide;idarubicin;melphalan
16	Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma	Unknown status	NCT00003815	Phase 3	carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
17	Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma	Unknown status	NCT00053768	Phase 3	EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
18	Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma	Unknown status	NCT00052936	Phase 3	CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
19	Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma	Unknown status	NCT00003924	Phase 3
20	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Completed	NCT00408005	Phase 3	Asparaginase;Cyclophosphamide;Cytarabine;Daunorubicin Hydrochloride;Dexamethasone;Doxorubicin Hydrochloride;Leucovorin Calcium;Mercaptopurine;Methotrexate;Nelarabine;Pegaspargase;Prednisone;Thioguanine;Vincristine Sulfate
21	Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma	Completed	NCT00003187	Phase 2, Phase 3	cyclophosphamide;cyclosporine;cytarabine;methotrexate;methylprednisolone
22	A Study of Actonel for the Prevention of Bone Loss	Completed	NCT00452439	Phase 3	Actonel (Risedronate)
23	Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma	Completed	NCT00002766	Phase 3	carmustine;cyclophosphamide;cytarabine;daunorubicin hydrochloride;doxorubicin hydrochloride;etoposide;mercaptopurine;methotrexate;mitoxantrone hydrochloride;pegaspargase;prednisone;vincristine sulfate
24	Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III	Completed	NCT00483132	Phase 3	interferon alpha 2a
25	Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications	Completed	NCT00799461	Phase 3
26	Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma	Completed	NCT01230983	Phase 3	asparaginase;cytarabine;dexrazoxane hydrochloride;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;therapeutic hydrocortisone;vincristine sulfate
27	Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia	Completed	NCT00002700	Phase 3	asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;mitoxantrone hydrochloride;prednisolone;prednisone;therapeutic hydrocortisone;vincristine sulfate
28	Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial	Completed	NCT00750009	Phase 3
29	American Ginseng in Treating Patients With Fatigue Caused by Cancer	Completed	NCT00719563	Phase 3	American ginseng
30	Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain	Completed	NCT00666211	Phase 3
31	Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer	Completed	NCT00661999	Phase 3	sodium ferric gluconate complex in sucrose
32	Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain	Completed	NCT00538850	Phase 3	Fentanyl sublingual spray;Placebo
33	Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count	Completed	NCT00003805	Phase 3	piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin
34	Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients	Completed	NCT00003938	Phase 3	liposomal amphotericin B
35	Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant	Completed	NCT00305851	Phase 3
36	Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer	Completed	NCT00265837	Phase 3
37	St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer	Completed	NCT00005805	Phase 3
38	Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter	Completed	NCT00006083	Phase 3	Fragmin
39	Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation	Completed	NCT00004230	Phase 3	captopril;cyclophosphamide
40	Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation	Completed	NCT00014391	Phase 3	ribavirin
41	Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation	Completed	NCT00003883	Phase 3	fluconazole;itraconazole
42	Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment	Completed	NCT00008359	Phase 3	caspofungin acetate;liposomal amphotericin B
43	Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma	Completed	NCT00005590	Phase 3	levofloxacin
44	Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma	Completed	NCT00002576	Phase 3	cyclophosphamide;doxorubicin hydrochloride;mitoxantrone hydrochloride;prednisolone;vincristine sulfate
45	Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation	Completed	NCT00045292	Phase 3	acyclovir;acyclovir sodium;valacyclovir
46	Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment	Completed	NCT00006348	Phase 3	ondansetron
47	Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer	Completed	NCT00369564	Phase 3	glutamic acid
48	Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases	Completed	NCT00438958	Phase 3
49	Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer	Completed	NCT00053053	Phase 3
50	Treatment for Chronic Pain in Patients With Advanced Cancer	Completed	NCT00003687	Phase 3	dextromethorphan hydrobromide;morphine sulfate

Search NIH Clinical Center for Lymphoblastic Lymphoma

Inferred drug relations via UMLS ⁷³ / NDF-RT ⁵¹ :

asparaginase

cyclophosphamide

idarubicin

idarubicin hydrochloride

ifosfamide

mercaptopurine

pegaspargase

sargramostim

Cell-based therapeutics:

Data from LifeMap, the Embryonic Development and Stem Cells Database

Read about Lymphoblastic Lymphoma cell therapies at LifeMap Discovery.

Stem-cell-based therapeutic approaches for Lymphoblastic Lymphoma:

	Blood stem cell transplantation for hematological diseases
	Hematopoietic stem cells for treatment of hematologic malignancies
	Peripheral blood stem cells for treatment of hematologic malignancies

Embryonic/Adult Cultured Cells Related to Lymphoblastic Lymphoma:

	Peripheral blood-derived hematopoietic stem cells (family)
	Bone marrow-derived hematopoietic stem cells

Sources

Genetic Tests for Lymphoblastic Lymphoma

Sources

Anatomical Context for Lymphoblastic Lymphoma

MalaCards organs/tissues related to Lymphoblastic Lymphoma:

⁴¹

T Cells, Bone, Bone Marrow, B Cells, Lymph Node, B Lymphoblasts, Myeloid

The Foundational Model of Anatomy Ontology organs/tissues related to Lymphoblastic Lymphoma:

¹⁹

Primarily Lymph Nodes Or

Sources

Publications for Lymphoblastic Lymphoma

Articles related to Lymphoblastic Lymphoma:

(show top 50) (show all 672)

#	Title	Authors	Year
1	Transformation of T-Cell Acute Lymphoblastic Lymphoma to Peripheral T-Cell Lymphoma: A Report of Two Cases. ( 29682368 )	Markow M....Hussaini M.O.	2018
2	Lymphoblastic Lymphoma Involving Multiple Vertebrae. ( 28962960 )	Li D....Wu Z.	2018
3	Pediatric Patient With T-Cell Lymphoblastic Lymphoma and Acute Vision Loss. ( 29121170 )	Chen T.H....Shah H.A.	2018
4	Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group. ( 29090524 )	Rau R.E....Hunger S.P.	2018
5	Terminal deoxynucleotidyl transferase (TdT)-negative T-cell lymphoblastic lymphoma with loss of the T-cell lineage-specific marker CD3 at relapse: a rare entity with an aggressive outcome. ( 29884716 )	Hassan M....Qamar M.A.	2018
6	Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngers. ( 29348421 )	Dong M....Chen Q.	2018
7	Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. ( 29047158 )	Abaza Y....Ravandi F.	2018
8	Myositis in bilateral calves mimicking lymphoma on interim PET/CT in a patient with T-lymphoblastic lymphoma. ( 29590432 )	Seo M....Park S.H.	2018
9	Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma. ( 29712994 )	Yang L....Luo Y.	2018
10	Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults. ( 29418064 )	McNeer J.L....Bleyer A.	2018
11	A case report of B lymphoblastic lymphoma with brain metastases: Clinical and pathological significance of head trauma misdiagnosis. ( 29768334 )		2018
12	Successful treatment of pulmonary invasive fungal infection by <i>Penicillium</i> non<i>-marneffei</i> in lymphoblastic lymphoma: case report and literature review. ( 29881585 )		2018
13	Precursor T-Lymphoblastic Lymphoma Associated with t(8;9)(p11.2;q33): A Case Report and Review of the Literature. ( 29614500 )		2018
14	T Cell-Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation for Treatment of T-Lymphoblastic Lymphoma. ( 29930241 )		2018
15	Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial-mesenchymal transition via regulating the PI3K/AKT/mTOR pathway. ( 29483777 )		2018
16	Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report. ( 30313079 )	Wang P...Feng Y	2018
17	Coexistence of T-cell lymphoblastic lymphoma and acute myeloid leukemia mimicking acute lymphocytic leukemia. ( 30004087 )	Liu K...Li W	2018
18	T-Cell Acute Lymphoblastic Lymphoma Presenting as Dissecting Cellulitis and Cavernous Sinus Syndrome. ( 30418330 )	Mattingly JJ...Yalamanchili SS	2018
19	Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation. ( 29995776 )	Hu M...Jin J	2018
20	Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia. ( 30466764 )	Yang K...Xi Y	2018
21	Philadelphia chromosome-positive lymphoblastic lymphoma-Is it rare or underdiagnosed? ( 29913129 )	Alshomar A...El Fakih R	2018
22	Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens. ( 30058716 )	Siegel SE...Bleyer A	2018
23	A Young Manwith a Mass: Non-Early Precursor T-Cell Lymphoblastic Lymphoma. ( 30138599 )	Jiang Y...Kanaan Z	2018
24	Phase II Clinical Trial for Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma (Japanese Leukemia/Lymphoma Study Group Trial LLB-NHL03) : Study Protocol for Nationwide Multicenter Trial. ( 30140093 )	Sekimizu M...Sunami S	2018
25	Lymphoblastic Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). ( 30238900 )	Dabaja BS...Yahalom J	2018
26	B-lymphoblastic lymphoma with the TCF3-PBX1 fusion gene. ( 30262566 )	Kubota-Tanaka M...Takagi M	2018
27	T-lymphoblastic lymphoma after previous thymoma: how NGS helps establishing the diagnosis and procures new insights. ( 30301393 )	Le Clef Q...Tzankov A	2018
28	T-cell lymphoblastic lymphoma involving the ocular adnexa: report of two cases and review of the current literature. ( 30396307 )	Sun L...Freidl KB	2018
29	A Rare Presentation of Precursor B-cell Lymphoblastic Lymphoma in a Child. ( 30410844 )	Javed Z...Hanif F	2018
30	B-cell lymphoblastic lymphoma of the nictitating membrane as the first presenting sign in a 2-year-old Springer Spaniel. ( 30455930 )	Holm F...Heegaard S	2018
31	MEG3 affects the progression and chemoresistance of T-cell lymphoblastic lymphoma by suppressing epithelial-mesenchymal transition via the PI3K/mTOR pathway. ( 30556337 )	Deng R...Su Y	2018
32	Case Report: A Cryptosporidium infection in a patient with relapsed T-lymphoblastic lymphoma undergoing allogeneic stem cell transplantation. ( 29140544 )	Schiller J....FlA1mann R.	2017
33	Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review. ( 29143359 )	Yasuda H....Komatsu N.	2017
34	Myeloid Neoplasia and Lymphoblastic Lymphoma with Eosinophilia After RAI: A Case Report. ( 28958974 )	BA1yA1kA9imA9ek M....Ergin M.	2017
35	Clinical impact of miR-223 expression in pediatric T-Cell lymphoblastic lymphoma. ( 29296210 )	Pomari E....Mussolin L.	2017
36	Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD. ( 28778131 )	Kato H....Kinoshita T.	2017
37	Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens. ( 28646517 )	Jain P....Jabbour E.	2017
38	Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma. ( 28827401 )	SimA^n-Carrasco L....Barbacid M.	2017
39	A CD34-negative <i>MYC</i>-rearranged B-lymphoblastic lymphoma aberrantly expresses CD3 and CD5. ( 28280048 )	Wang H.Y....Thorson J.A.	2017
40	Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant. ( 29313927 )	Luo Y....Liu J.	2017
41	The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma. ( 28534937 )	Fan F.Y....Su Y.	2017
42	Lymphoblastic lymphoma of the palate. ( 28966460 )	Nambiar R....Devi N.	2017
43	B-cell lymphoblastic lymphoma presenting as solitary temporal mass with amplification of AML1/RUNX1: case report. ( 28933515 )	Sabatino R....Franco R.	2017
44	Successful Treatment of Mediastinal I^I' T-Cell Lymphoblastic Lymphoma in a 3-Year-Old Girl by Allogeneic Cord Blood Transplantation. ( 29200146 )	Hori D....Kobayashi K.	2017
45	Prognostic Factors and Outcomes of Adult Lymphoblastic Lymphoma in the United States. ( 28647403 )	El-Fattah M.A.	2017
46	Philadelphia chromosome-positive B-lymphoblastic lymphoma involving the genitourinary system and bone at initial diagnosis and relapse. ( 28935645 )	Zheng L....Hu S.	2017
47	JSH guideline for tumors of hematopoietic and lymphoid tissues-leukemia: 3. Acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL/LBL). ( 29067593 )	TAKEUCHI J....Izutsu K.	2017
48	Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients. ( 28082512 )	Eymard N....Nony P.	2017
49	Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study. ( 28771663 )	Zwaan C.M....Leverger G.	2017
50	Ecthyma gangrenosum in a case of acute lymphoblastic lymphoma. ( 28052953 )	Mishra K....Malhotra P.	2017

Sources

Genes for Lymphoblastic Lymphoma

Genes related to Lymphoblastic Lymphoma (0 elite genes):

(show all 15)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	ZMYM2	Zinc Finger MYM-Type Containing 2	Protein Coding	32.16	DISEASES inferred ¹⁵ GeneCards inferred via : Disorders Publications (show sections)
2	PTPRC	Protein Tyrosine Phosphatase, Receptor Type C	Protein Coding	30.11	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	11190795 7503935
3	FGFR1	Fibroblast Growth Factor Receptor 1	Protein Coding	28.01	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Disorders (show sections)	11919391
4	TAL1	TAL BHLH Transcription Factor 1, Erythroid Differentiation Factor	Protein Coding	27.79	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	9116269 9171354
5	BCL6	BCL6, Transcription Repressor	Protein Coding	27.78	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	11133771 9310496
6	NOTCH1	Notch 1	Protein Coding	27.61	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	18663146
7	CDKN2B	Cyclin Dependent Kinase Inhibitor 2B	Protein Coding	27.05	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	7882348 8656689 8637248 (more) 15475071
8	FLI1	Fli-1 Proto-Oncogene, ETS Transcription Factor	Protein Coding	26.54	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	19349856 11117787
9	CEP85L	Centrosomal Protein 85 Like	Protein Coding	26.31	GeneCards inferred via : Disorders Expressions (show sections)
10	MPO	Myeloperoxidase	Protein Coding	25.8	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	7513945 8037168
11	DNTT	DNA Nucleotidylexotransferase	Protein Coding	25.13	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	11190795 18480005 7937725 (more) 9042293 9175304 16217262 9353824 19633642 18341382 17885674 9343323 9227346 9422326 1996546 1859892 9110287
12	MME	Membrane Metalloendopeptidase	Protein Coding	23.02	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
13	TRB	T Cell Receptor Beta Locus	Protein Coding	22.46	Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	1701841 15132850
14	CD5	CD5 Molecule	Protein Coding	22.45	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
15	KMT2A	Lysine Methyltransferase 2A	Protein Coding	22.16	Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	10602439

Sources

Variations for Lymphoblastic Lymphoma

Sources

Expression for Lymphoblastic Lymphoma

Search GEO for disease gene expression data for Lymphoblastic Lymphoma.

Sources

Pathways for Lymphoblastic Lymphoma

Pathways related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	NF-kappaB Signaling ⁴	12.07	BCL6 FLI1 MPO PTPRC TAL1
2	Transcriptional misregulation in cancer ³⁷	11.83	BCL6 FLI1 KMT2A MPO
3	Hematopoietic cell lineage ³⁷	11.48	CD5 DNTT MME
4	Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers ⁶⁵	11.09	CD5 MME MPO NOTCH1 PTPRC
5	B Cell Development Pathways ⁶⁵	10.98	BCL6 CD5 MME PTPRC
6	A-beta Pathways: Uptake and Degradation ⁶⁵	10.87	MME PTPRC

Sources

GO Terms for Lymphoblastic Lymphoma

Biological processes related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	regulation of hematopoietic stem cell differentiation	GO:1902036	9.4	KMT2A TAL1
2	cellular response to extracellular stimulus	GO:0031668	9.37	CDKN2B PTPRC
3	embryonic hemopoiesis	GO:0035162	9.32	KMT2A TAL1
4	megakaryocyte development	GO:0035855	9.26	FLI1 TAL1
5	generation of neurons	GO:0048699	9.16	FGFR1 TAL1
6	megakaryocyte differentiation	GO:0030219	8.96	CDKN2B TAL1
7	regulation of cell proliferation	GO:0042127	8.92	BCL6 FGFR1 NOTCH1 TAL1

Molecular functions related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	DNA-binding transcription factor activity	GO:0003700	9.65	BCL6 FLI1 KMT2A NOTCH1 TAL1
2	heparin binding	GO:0008201	9.33	FGFR1 MPO PTPRC
3	RNA polymerase II distal enhancer sequence-specific DNA binding	GO:0000980	9.13	FLI1 KMT2A TAL1
4	chromatin binding	GO:0003682	9.02	BCL6 FLI1 MPO NOTCH1 TAL1

Sources

Sources for Lymphoblastic Lymphoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia

Lymphoblastic Lymphoma

Aliases & Classifications for Lymphoblastic Lymphoma

MalaCards integrated aliases for Lymphoblastic Lymphoma:

Classifications:

External Ids:

Summaries for Lymphoblastic Lymphoma

Related Diseases for Lymphoblastic Lymphoma

Diseases related to Lymphoblastic Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Lymphoblastic Lymphoma:

Symptoms & Phenotypes for Lymphoblastic Lymphoma

GenomeRNAi Phenotypes related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

MGI Mouse Phenotypes related to Lymphoblastic Lymphoma:

Drugs & Therapeutics for Lymphoblastic Lymphoma

FDA approved drugs:

Drugs for Lymphoblastic Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Inferred drug relations via UMLS 73 / NDF-RT 51 :

Cell-based therapeutics:

Genetic Tests for Lymphoblastic Lymphoma

Anatomical Context for Lymphoblastic Lymphoma

MalaCards organs/tissues related to Lymphoblastic Lymphoma:

The Foundational Model of Anatomy Ontology organs/tissues related to Lymphoblastic Lymphoma:

Publications for Lymphoblastic Lymphoma

Articles related to Lymphoblastic Lymphoma:

Genes for Lymphoblastic Lymphoma

Genes related to Lymphoblastic Lymphoma (0 elite genes):

Variations for Lymphoblastic Lymphoma

Expression for Lymphoblastic Lymphoma

Pathways for Lymphoblastic Lymphoma

Pathways related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

GO Terms for Lymphoblastic Lymphoma

Biological processes related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

Molecular functions related to Lymphoblastic Lymphoma according to GeneCards Suite gene sharing:

Sources for Lymphoblastic Lymphoma

Inferred drug relations via UMLS ⁷³ / NDF-RT ⁵¹ :